Existing pharmacological studies showed that ALA exerted antitumor activity mainly by inhibiting the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and affecting various key signal molecules involved in cancer progression (Chun et al., 2015). The gene discussed is STAT3; the disease is cancer.